Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma (TURCOS)

Share this content:
Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma (TURCOS)

Sponsors and Collaborators
Bayer

Contact
Bayer Clinical Trials Contact
clinical-trials-contact@bayerhealthcare.com

ClinicalTrials.gov Identifier|
NCT01585974

You must be a registered member of Renal and Urology News to post a comment.